Darren Hodgson

Darren Hodgson

AstraZeneca, Sweden - Södertälje / Sweden
Others
AD Scientific Index ID: 4400523
-
person_outline Darren Hodgson's MOST POPULAR ARTICLES
1-) Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised …J Ledermann, P Harter, C Gourley, M Friedlander, I Vergote, G Rustin, ...The lancet oncology 15 (8), 852-861, 201415132014
2-) Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo …JA Ledermann, P Harter, C Gourley, M Friedlander, I Vergote, G Rustin, ...The lancet oncology 17 (11), 1579-1589, 20164232016
3-) Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trialN Clarke, P Wiechno, B Alekseev, N Sala, R Jones, I Kocak, VE Chiuri, ...The Lancet Oncology 19 (7), 975-986, 20182732018
4-) Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo …YJ Bang, RH Xu, K Chin, KW Lee, SH Park, SY Rha, L Shen, S Qin, N Xu, ...The lancet oncology 18 (12), 1637-1651, 20172932017
5-) Randomized, double-blind phase II trial with prospective classification by ATM protein level to evaluate the efficacy and tolerability of olaparib plus paclitaxel in patients …YJ Bang, SA Im, KW Lee, JY Cho, EK Song, KH Lee, YH Kim, JO Park, ...Journal of clinical oncology 33 (33), 3858-3865, 20152762015